Dr Reddys Laboratories (RDY) Gains from Sales and Divestitures (2010 - 2019)
Dr Reddys Laboratories' Gains from Sales and Divestitures came in at -$27 million for the year ended Mar 31, 2026, compared with -$18 million a year earlier.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Gains from Sales and Divestitures (2010 - 2019) Analysis & Trends
Going back to the year ended Mar 31, 2010, Dr Reddys Laboratories' Gains from Sales and Divestitures data covers 15 years.
- The figure for the year ended Mar 31, 2026 represents the lowest annual Gains from Sales and Divestitures since the year ended Mar 31, 2011.
- Per Business Quant, earlier years put Gains from Sales and Divestitures at -$18 million in the year ended Mar 31, 2025, -$11 million in the year ended Mar 31, 2024, $3 million in the year ended Mar 31, 2023 and -$15 million in the year ended Mar 31, 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.41 Bn | 396.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 1.22 Mn |
| Jun 30, 2019 | -71,773.93 |
| Mar 31, 2019 | -3.13 Mn |
| Jun 30, 2018 | -1.02 Mn |
| Mar 31, 2018 | 528,494.32 |
| Dec 31, 2017 | 355,407.17 |
| Sep 30, 2017 | -93,351.88 |
| Dec 31, 2016 | -267,152.33 |
| Sep 30, 2016 | 29,880.58 |
| Dec 31, 2015 | 15,179.06 |
| Sep 30, 2015 | -61,635.72 |
| Jun 30, 2015 | 410,531.89 |
| Mar 31, 2015 | 1.65 Mn |
| Dec 31, 2014 | 16,158.24 |
| Mar 31, 2014 | 81,027.20 |
| Dec 31, 2013 | -499,871.16 |
| Sep 30, 2013 | 16,126.93 |
| Jun 30, 2013 | -503,217.56 |
| Mar 31, 2013 | -3.14 Mn |
| Dec 31, 2012 | 129,376.93 |
API Access
Dr Reddys Laboratories Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();